WallStreetZenWallStreetZen

NASDAQ: VNDA
Vanda Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their VNDA stock forecasts and price targets.

Forecast return on equity

Is VNDA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.5%

Forecast return on assets

Is VNDA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

VNDA revenue forecast

What is VNDA's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$188.0M-2.41%
Avg 2 year Forecast
$175.3M-9%
VNDA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VNDA earnings growth forecast

How is VNDA forecast to perform vs Biotechnology companies and vs the US market?
Company
102.06%
Industry
7.2%
Market
22.04%
VNDA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
VNDA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
VNDA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

VNDA revenue growth forecast

How is VNDA forecast to perform vs Biotechnology companies and vs the US market?
Company
10.67%
Industry
38.94%
Market
10.52%
VNDA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VNDA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VNDA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VNDA$3.89N/AN/A
NBTX$6.35$11.00+73.23%Buy
VXRT$1.29$2.00+55.04%Strong Buy
CGEN$2.54$4.50+77.17%Strong Buy
DSGN$3.91$4.50+15.09%Hold

Vanda Pharmaceuticals Stock Forecast FAQ

What is VNDA's revenue growth forecast for 2024-2025?

(NASDAQ: VNDA) Vanda Pharmaceuticals's forecast annual revenue growth rate of 10.67% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Vanda Pharmaceuticals's revenue in 2024 is $192,640,000.On average, 1 Wall Street analysts forecast VNDA's revenue for 2024 to be $10,817,049,812, with the lowest VNDA revenue forecast at $10,817,049,812, and the highest VNDA revenue forecast at $10,817,049,812.

In 2025, VNDA is forecast to generate $10,086,323,575 in revenue, with the lowest revenue forecast at $10,086,323,575 and the highest revenue forecast at $10,086,323,575.

If you're new to stock investing, here's how to buy Vanda Pharmaceuticals stock.

What is VNDA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: VNDA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is VNDA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: VNDA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.